These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression. Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837 [TBL] [Abstract][Full Text] [Related]
7. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers. Kori M; Aydin B; Gulfidan G; Beklen H; Kelesoglu N; Caliskan Iscan A; Turanli B; Erzik C; Karademir B; Arga KY OMICS; 2021 Mar; 25(3):139-168. PubMed ID: 33404348 [TBL] [Abstract][Full Text] [Related]
9. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer. Sethi MK; Fanayan S Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136 [TBL] [Abstract][Full Text] [Related]
10. Cancer glycomics offers potential biomarkers and therapeutic targets in the framework of 3P medicine. Guo Y; Jia W; Yang J; Zhan X Front Endocrinol (Lausanne); 2022; 13():970489. PubMed ID: 36072925 [TBL] [Abstract][Full Text] [Related]
11. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185 [TBL] [Abstract][Full Text] [Related]
12. A glycomics approach to the discovery of potential cancer biomarkers. An HJ; Lebrilla CB Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a combined glycomics and glycoproteomics approach for studying the major glycoproteins present in biofluids: Application to cerebrospinal fluid. Goyallon A; Cholet S; Chapelle M; Junot C; Fenaille F Rapid Commun Mass Spectrom; 2015 Mar; 29(6):461-73. PubMed ID: 26160412 [TBL] [Abstract][Full Text] [Related]
15. Glycosylation and its implications in breast cancer. Scott DA; Drake RR Expert Rev Proteomics; 2019 Aug; 16(8):665-680. PubMed ID: 31314995 [No Abstract] [Full Text] [Related]
16. Unique to this volume is the subsequent focus of individual chapters on what is known about glycosylation in relation to specific organ sites of cancer. Preface. Drake RR; Ball L Adv Cancer Res; 2015; 126():xiii-xiv. PubMed ID: 25727154 [No Abstract] [Full Text] [Related]
17. Sweet systems: technologies for glycomic analysis and their integration into systems biology. Chen S; Qin R; Mahal LK Crit Rev Biochem Mol Biol; 2021 Jun; 56(3):301-320. PubMed ID: 33820453 [TBL] [Abstract][Full Text] [Related]
18. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Thomas D; Rathinavel AK; Radhakrishnan P Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188464. PubMed ID: 33157161 [TBL] [Abstract][Full Text] [Related]
19. The clinical role of glycobiology on ovarian cancer progression. Armbrister R; Ochoa L; Abbott KL Adv Cancer Res; 2023; 157():1-22. PubMed ID: 36725106 [TBL] [Abstract][Full Text] [Related]
20. Cellular O-Glycome Reporter/Amplification (CORA): Analytical and Preparative Tools to Study Mucin-Type O-Glycans of Living Cells. Kudelka MR; Li Z; Chernova TA; Smith DF; Song X; Cummings RD; Ju T Curr Protoc; 2021 Jun; 1(6):e142. PubMed ID: 34101390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]